Back to results
US 10,765,684 B2Granted
Reduction of side effects from aromatase inhibitors used for treating breast cancer
AssigneeHavah Therapeutics Pty Ltd.
InventorStephen Nigel Birrell
Life of this patent
Estimating the term…
Abstract
The present invention is directed generally to pharmaceutical compositions, methods, and kits for improving side effects associated with aromatase inhibitor treatment in a subject diagnosed with breast cancer. More specifically, the present invention provides compositions, methods, and kits comprising an aromatase inhibitor and an androgenic agent.
Claims19
A method of mitigating one or more side effects in a postmenopausal patient being treated for breast cancer, comprising administering to said patient:
- a) 30-50 mg per day of testosterone or testosterone undecanoate;
- and
- b) an effective amount per day of an aromatase inhibitor;
- wherein the mitigated one or more side effects comprises urinary tract infection or breast pain.
1 more element
Dependencies are inferred from the claim text.